Correction: Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy

Mari Iida, Toni M. Brand, Megan M. Starr, Evan J. Huppert, Neha Luthar, Harsh Bahrar, John P. Coan, Hannah E. Pearson, Ravi Salgia, Deric L. Wheeler · 2025

Read Correction: Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy by Mari Iida, Toni M. Brand, Megan M. Starr, Evan J. Huppert, Neha Luthar, Harsh Bahrar, John P. Coan, Hannah E. Pearson, Ravi Salgia, Deric L. Wheeler (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12752348.txt.

Description

R, EGFR, pMAPK, MAPK, and α-tubulin were inadvertently sourced from a previous publication. After working closely with the editorial team, the authors have now provided the correct blots for Figure 1A. This correction does not impact the findings or conclusions of the article.

Catalog record

CREATORMari Iida, Toni M. Brand, Megan M. Starr, Evan J. Huppert, Neha Luthar, Harsh Bahrar, John P. Coan, Hannah E. Pearson, Ravi Salgia, Deric L. Wheeler
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE3 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12752348

Browse the full library · About the Tower of Babel